PATZF Stock UPDATES Patrys Ltd Mel (PATZF) 0.0350 09/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Patrys Ltd Mel (PATZF) 0.0350 $PATZF

Staphylococcus Aureus Infections - Pipeline Review, H2 2013 Report
M2 - Wed Feb 19, 2:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/jg3jt3/staphylococcus) has announced the addition of the "Staphylococcus Aureus Infections - Pipeline Review, H2 2013" report to their offering. 'Staphylococcus Aureus Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Staphylococcus Aureus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Staphylococcus Aureus Infections. Scope - A snapshot of the global therapeutic scenario for Staphylococcus Aureus Infections. - A review of the Staphylococcus Aureus Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Staphylococcus Aureus Infections pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Staphylococcus Aureus Infections Overview Therapeutics Development Clinical Stage Products Early Stage Products Unknown Stage Products Staphylococcus Aureus Infections - Therapeutics Assessment Drug Profiles lysostaphin - Drug Profile WCK-771 - Drug Profile avarofloxacin hydrochloride - Drug Profile PF-06290510 - Drug Profile P-128 - Drug Profile GSK-2392106A - Drug Profile STEBVax - Drug Profile GSK-2392105A - Drug Profile GSK-2392103A - Drug Profile GSK-2392019A - Drug Profile NDV-3 Vaccine - Drug Profile SASPject PT1.2 - Drug Profile GSK-2392102A - Drug Profile Staphylococcus Aureus Vaccine - Drug Profile MEDI-4893 - Drug Profile MORAb-048 - Drug Profile gallium citrate Ga 67 - Drug Profile Staphylococcus Aureus Vaccine - Drug Profile NVC-727 - Drug Profile SEB-HIG - Drug Profile SEB-HuMab - Drug Profile Bactericidal Venom-Based Polypeptides - Drug Profile MGB-BP-3 - Drug Profile Second Generation Oxas - Drug Profile Novarifyn - Drug Profile AQP-182 - Drug Profile niacinamide - Drug Profile Vaccine For Staphylococcus - Drug Profile and many more..... Featured News & Press Releases Appendix List of Tables List of Figures Some of the Companies Mentioned AstraZeneca PLC GlaxoSmithKline plc Genentech, Inc. Daiichi Sankyo Company, Limited Merck & Co., Inc. Exploit Technologies Pte Ltd Imaxio Novartis AG Actelion Ltd Pfizer Inc. Wockhardt Limited NovaBay Pharmaceuticals, Inc. Patrys Limited Galapagos NV Microbio Co., Ltd. Morphotek, Inc. Bharat Biotech International Limited Novabiotics Ltd GlycoVaxyn AG Priaxon AG Aquapharm Biodiscovery Limited Aridis Pharmaceuticals LLC For more information visit http://www.researchandmarkets.com/research/jg...hylococcus About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Colon Cancer - Pipeline Review, H2 2013 Gives Coverage of the Colon Cancer Pipeline on the Basis of Route of Administration and Molecule Type
M2 - Mon Aug 12, 12:10PM CDT
Research and Markets (http://www.researchandmarkets.com/research/kfjngz/colon_cancer) has announced the addition of the "Colon Cancer - Pipeline Review, H2 2013" report to their offering. Global Markets Direct's, 'Colon Cancer - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Colon Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Colon Cancer. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Colon Cancer. - A review of the Colon Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned: - AEterna Zentaris Inc. - Advenchen Laboratories, LLC - Affichem - Alethia Biotherapeutics Inc. - AlphaVax, Inc. - Cell Therapeutics, Inc. - Curis, Inc. - Cytokinetics, Inc - DEKK-TEC, Inc. - Eli Lilly and Company - Etubics Corporation - Five Prime Therapeutics, Inc. - Geistlich Pharma AG - ISA Pharmaceuticals B.V. - Isofol Medical AB - Kalos Therapeutics, Inc. - Lorus Therapeutics Inc - MabVax Therapeutics, Inc. - Northwest Biotherapeutics, Inc. - NovaLead Pharma Pvt. Ltd. - OncoMed Pharmaceuticals, Inc. - OncoVista Innovative Therapies, Inc. - Patrys Limited - PharmaMar, S.A. - Pharminox Limited - Pique Therapeutics - Tautatis Incorporated - Telik, Inc. - Transgene Biotek Ltd - Viventia Biotechnolo For more information visit http://www.researchandmarkets.com/research/kf...lon_cancer About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phoenix Reveals Cost-Saving Hacks for Transfer Students

Updated Category News Views 5

Making College Cost Manageable Okay, let's get real about college costs. Tuition fees got folks holding their breath tighter than a bull in a bear market. University of Phoenix ain't turning a blind eye—during National Transfer Student Week, they're shouting from the rooftops about pocket-friendly ways to snag that degree without selling your soul or flipping another...

Continue Reading
Chemours Set to Release Q3 2026 Results This November

Updated Category News Views 3

Mark Your Calendars for Chemours' Upcoming Earnings If you've got a hand in Chemours' pie, circle November 2 on your calendar. That's the day they pull back the curtain on their Q3 2026 financial results. It's an after-market reveal, and if you're hoping to catch the full picture, they've lined up a conference call at 8:00 a.m. EST the very next day, on November 3. Early...

Continue Reading
European Flavors: A Halloween Food Revolution

Updated Category News Views 4

Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...

Continue Reading
Mili and Egnyte Transform Financial Advice Delivery

Updated Category News Views 6

AI Powers Up Financial Advisors with New Partnership Ah, the grind never ends for those financial advisors, right? Well, here's a nugget that might just lighten their load. Mili and Egnyte are buddying up to merge AI with secure content platforms, aiming to supercharge how advisors handle client documents. Right off the bat, advisors can crank out personalized advice at a...

Continue Reading
Ellevio Bolsters Stockholm Grid with SEK 1B NIB Loan

Updated Category News Views 6

In a move that packs plenty of juice for Stockholm's energy needs, Ellevio has shaken hands with the Nordic Investment Bank (NIB) in a hefty SEK 1 billion loan agreement. This isn’t just some pocket change—this financing is a ticket to revamping and beefing up the Beckomberga substation, a project hailed for fortifying the regional electricity grid in the Swedish...

Continue Reading
Platform9: Strategic Private Cloud Innovator Emerges

Updated Category News Views 6

Shifting Sands in Private Cloud Infrastructure Here's a nugget for those keeping tabs on infrastructure shifts: Platform9 just got its ticket punched as a Major Player in the latest IDC MarketScape assessment for worldwide private cloud infrastructure software vendors. And if you've been in this game as long as I have, you know this isn't just a bit of puffery—the IDC...

Continue Reading
Husqvarna's Q3 Numbers: A Mixed Bag of Woes and Wins

Updated Category News Views 6

Walking into Husqvarna’s latest interim report, it’s clear they’re facing an uphill struggle. Third quarter numbers can sting when they’re not in line with expectations, and Huskie's feeling the burn with a dip in net sales by 5% organically. Just look at that grimace on their bottom line—their operating income has hit SEK -334 million, a significant drop from...

Continue Reading
Vermiculus Unveils VeriIndex: A Game-Changer for Indices

Updated Category News Views 4

Standing on the Precipice of Index Innovation There’s a seismic shift rumbling through Vermiculus as they roll out their latest brainchild, the VeriIndex. This isn’t just your typical release; it’s the kind of shakeup that slaps you awake like a splash of cold water. Ever since they burst onto the scene in 2020, Vermiculus has been stirring the pot of exchange...

Continue Reading
AI Traffic Sensing By AglaiaSense and Leopard Imaging

Updated Category News Views 9

Revolutionizing Traffic Sensing with Privacy The buzz in Barcelona this November is all about AglaiaSense and Leopard Imaging teaming up at the Smart City Expo World Congress. They're not just hitting exhibit after exhibit. These two are set to roll out their cutting-edge AI traffic sensing tech, and from what I'm hearing, it's miles ahead of anything we've seen before....

Continue Reading
KingClean's New Tech at Canton Fair Ignites Interest

Updated Category News Views 9

KingClean Stirs the Pots at Canton Fair Stretching over the bustling floors of the 140th Canton Fair, KingClean has rolled out its latest innovations in the smart home appliance arena. Now, this isn't just another day at the market—KingClean's pushing the envelope on how household gear should perform and connect globally. Diving Into KingClean's Smart Arsenal At the...

Continue Reading

Top 5 Most Recently Viewed Articles

Cardano Experiences Significant Price Drop Amid Market Trends

Updated Category News Views 178

Cardano Faces a Significant Price Drop Recently, Cardano's price has fallen by 3.95% over just 24 hours, bringing it down to $0.33. This decline is part of a larger trend seen over the past week, with the cryptocurrency dropping by 4.0% from its previous price of $0.34. Analyzing Market Behavior The latest price dip highlights the ongoing volatility within Cardano's...

Continue Reading
Innofactor's Recent Managerial Transactions and Insights

Updated Category News Views 116

Overview of Recent Managerial Transactions at Innofactor Plc On a notable day in November, a series of transactions took place at Innofactor Plc, highlighting the ongoing engagement of its managerial team. The transactions were officially recorded on November 11, closely monitored by interested parties within the Finnish market. Key Individuals Involved Innofactor Plc's...

Continue Reading
CBH Homes Initiates Construction of Innovative New HQ

Updated Category News Views 781

CBH Homes Begins Building Its New Headquarters CBH Homes has recently celebrated a significant milestone with the groundbreaking of their new headquarters, affectionately dubbed "The CBH Starship." This exciting development symbolizes the company's dedication to expanding its operations and enhancing efficiency. Situated in Caldwell, Idaho, this impressive...

Continue Reading
Arverne Group Welcomes Manoelle Lepoutre-Saint-M'leux to Board

Updated Category News Views 151

Arverne Group Welcomes New Board Member Arverne Group, a pioneering industrial organization focused on renewable underground resources, is excited to share the news of Manoelle Lepoutre-Saint-M'leux joining its Board of Directors. Her appointment is pivotal as it demonstrates Arverne Group's commitment to strengthening board governance with proven leaders in the industry....

Continue Reading
Empowering Girls through Education: A New Initiative is Born

Updated Category News Views 451

Empowering Girls through Education: A New Initiative is Born Education Cannot Wait (ECW), a prominent global fund focused on education in emergencies, has launched two groundbreaking grants, totaling $1.9 million. Partnering with organizations such as the United Nations Girls' Education Initiative (UNGEI) and Plan International Canada, these grants aim to transform gender...

Continue Reading